
Academic nephrologist @MonteNephrology @einsteinmed | @ASNKidney360 AE | Hypertension | HIV & kidney disease | glomerular disease | hiking 🥾🍃
Joined May 2013
- Tweets404
- Following333
- Followers351
- Likes2.2K
Molly Fisher retweeted
On Friday at #KidneyWk, Jordana B. Cohen, MD, MS, FASN, will receive the ASN-AHA Donald W. Seldin Young Investigator Award and present “The Future of Blood Pressure Management: Precision Care in a Data-Rich World.”
Read more in #ASNKidneyNews: kidney.pub/KN1810-13
Molly Fisher retweeted
A #ASNJASN study published simultaneously with #KidneyWk found that mortality rates declined among patients initiating hemodialysis with a central venous catheter (CVC) over the past decade, with a reduction in absolute excess risk associated with continued CVC use. kidney.pub/JASN1293
Molly Fisher retweeted
Resistant hypertension remains a major global challenge. Better BP monitoring, optimized multidrug therapy, and emerging precision treatments are improving how we diagnose and manage this high-risk condition. #Review in #ASNCJASN. kidney.pub/CJASN1266
Molly Fisher retweeted
Some people with HIV who carry high-risk APOL1 genes may be less likely to develop kidney disease if they also have the APOL1 p.N264K genetic variant. This finding in #ASNJASN may help doctors better understand an individual's kidney disease risk in the future. kidney.pub/JASN1235
Molly Fisher retweeted
A team-based intervention provides greater reduction in systolic blood pressure in patients with hypertension seen at federally qualified health centers compared with usual care, reports a new study in The New England Journal of Medicine. Read about the trial in #ASNKidneyNews: kidney.pub/KN1806-19?utm_sou…
Molly Fisher retweeted
Exciting news! 🌟 Celebrating two of our very own #Kidney360 editors for receiving @ASNKidney Midcareer Awards:
- Deputy Editor @DrTimmyLee1: Distinguished Leader Award
- Associate Editor @ChanchlaniRahul: Distinguished Researcher Award
Join us in congratulating them!
Molly Fisher retweeted
HIV-associated kidney diseases: progress, gaps, and future directions
🔺Outstanding review
doi.org/10.1128/cmr.00207-25
Molly Fisher retweeted
Welcome to the new #ASNKidney360 Editorial Team! We are proud to announce this stellar team: journals.lww.com/Kidney360/p…
Molly Fisher retweeted
Coronary artery disease is a barrier to kidney transplantation. This new meta-analysis in #ASNJASN investigates how many patients meet class 1 indication for revascularization. Read more: kidney.pub/JASN0890
Molly Fisher retweeted
Should nephrologists further implement genetic testing in patients with CKD? In this #ASNJASN study of adult CKD management, genetic testing showed diagnostic and clinical utility in the year following the reporting of test results. Read more: kidney.pub/JASN0913
Had a blast with my Kidney ⭐️’s at #KidneyWk
The future is bright! 💫
12
482
Molly Fisher retweeted
The Belding H. Scribner award will be awarded to Michael Allon, MD, current #ASNKidney360 Editor in Chief, today for his career-long contributions to the practice of nephrology. Read about his career and the award in #ASNKidneyNews kidney.pub/KN1710-54
Molly Fisher retweeted
Differentiating functional acute kidney injury (AKI) from structural/intrinsic AKI with tubular injury remains a clinical challenge. This #ASNKidney360 original research evaluates the implementation of urinary NGAL to distinguish these conditions in a cohort. Check it out: kidney.pub/KID0887
Molly Fisher retweeted
"Peer review is a cornerstone of scientific advancement - it ensures the integrity and quality of information that is used to generate further knowledge." - Monica Syet Ying Ng, an #ASNJASN Top Reviewer of 2025.
Molly Fisher retweeted
Genetic sex is an important determinant of kidney injury and repair, with female kidneys typically exhibiting greater resilience to AKI. This #ASNJASN research examines how augmenting Gsta2 expression in male proximal tubule cells affects resistance to IRI. kidney.pub/JASN0840
Molly Fisher retweeted
ASN welcomes Professor Charuhas V. Thakar, MD, FASN, as the new Editor-in-Chief of Kidney360. In this role, @CharuThakar aspires to "disseminate cutting-edge research in diverse areas of nephrology." His term begins January 1, 2026. kidney.pub/4e466Kr
#ASNKidney360
Molly Fisher retweeted
New findings shed light on the developmental origin of thin descending limb cells and highlight the importance of Hnf4a in regulating their formation. kidney.pub/JASN0721
#ASNJASN
#BasicResearch
Molly Fisher retweeted
Additional research on the gut-liver and gut-kidney axes is crucial for understanding their connection, with future studies exploring gut microbiota modulation through antibiotics, probiotics, prebiotics, or dietary interventions, according to a perspective in #ASNCJASN. bit.ly/CJASN0732
Molly Fisher retweeted
Treatment with SGLT2i in CKD patients is associated with distinct gut microbial composition and metabolite profiles, suggesting potential modulation of gut dysbiosis and metabolic pathways. bit.ly/KID0792
#ASNKidney360
Molly Fisher retweeted
PARASOL ☂️: Achieving proteinuria <0.7 g/g is associated with meaningful reduction in kidney failure risk in FSGS
#Nephpearls #NKFClinicals



























